Long-term management of recurrent papillary thyroid carcinoma treated with lenvatinib for over 5 years: a case report

BACKGROUND: Few reports exist of the long-term management of recurrent and progressive papillary thyroid carcinoma (PTC) with a tyrosine kinase inhibitor for over 5 years. CASE PRESENTATION: A 57-year-old woman was referred to a psychiatric hospital for the treatment of schizophrenia. The patient ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Imai, Tsuneo, Kobayashi, Hironobu, Senaha, Tetsu, Imaizumi, Toshiaki, Murata, Yoshiharu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8795247/
https://www.ncbi.nlm.nih.gov/pubmed/35084585
http://dx.doi.org/10.1186/s40792-022-01374-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8795247/
https://www.ncbi.nlm.nih.gov/pubmed/35084585
http://dx.doi.org/10.1186/s40792-022-01374-0

Ejemplares similares